Windtree Therapeutics Files 8-K
Ticker: WINTW · Form: 8-K · Filed: Aug 5, 2025 · CIK: 946486
| Field | Detail |
|---|---|
| Company | Windtree Therapeutics Inc /De/ (WINTW) |
| Form Type | 8-K |
| Filed Date | Aug 5, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, SEC Filing, Disclosure
TL;DR
Windtree Therapeutics filed an 8-K on Aug 5, 2025, mostly procedural stuff.
AI Summary
On August 5, 2025, Windtree Therapeutics, Inc. filed an 8-K report. The filing primarily serves as a notification of a Regulation FD Disclosure and includes financial statements and exhibits. No specific material events or financial figures were detailed in the provided excerpt.
Why It Matters
This 8-K filing indicates that Windtree Therapeutics is providing updated information or disclosures to the SEC, which could be relevant for investors monitoring the company's regulatory compliance and financial reporting.
Risk Assessment
Risk Level: low — The provided excerpt is a standard 8-K filing notification and does not contain specific material events or financial data that would indicate a change in risk.
Key Players & Entities
- Windtree Therapeutics, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- August 5, 2025 (date) — Date of earliest event reported
- 2600 Kelly Road, Suite 100, Warrington, Pennsylvania 18976 (address) — Principal executive office
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and to include financial statements and exhibits.
What is the exact name of the registrant as specified in its charter?
The exact name of the registrant is Windtree Therapeutics, Inc.
In which state was Windtree Therapeutics, Inc. incorporated?
Windtree Therapeutics, Inc. was incorporated in Delaware.
What is the address of Windtree Therapeutics, Inc.'s principal executive office?
The address of Windtree Therapeutics, Inc.'s principal executive office is 2600 Kelly Road, Suite 100, Warrington, Pennsylvania 18976.
What is the date of the earliest event reported in this filing?
The date of the earliest event reported in this filing is August 5, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on August 5, 2025 regarding WINDTREE THERAPEUTICS INC /DE/ (WINTW).